RIVM_Logo

Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel

 

Home / Documenten en publicaties / Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel

RIVM De zorg voor morgen begint vandaag
Menu